Allergy Therapeutics plc 47 Directors’ Remuneration Report 51 Nominations Committee Report 52 Audit Committee Report 54 Report of the Directors Financial Statements 59 Independent Auditor’s Report to the Members of Allergy Therapeutics plc 66 Consolidated Income Statement 67 Consolidated Statement of Comprehensive Income 68 Consolidated Balance Sheet 69 Consolidated Statement of Changes in Equity 70 Consolidated Cash Flow Statement 71 Notes to the Financial Statements 109 Company Balance Sheet 110 Statement of Changes in Equity (Company) 111 Notes to Company Balance Sheet 115 Shareholder Information Find this report online at allergytherapeutics.com 01 Highlights * Percentage based on figures in thousands (2017: £55.545m, 2016: £48.509m) ** Constant currency uses prior year weighted average exchange rates to translate current year foreign currency denominated revenue to give a year on year comparison excluding the effects of foreign exchange movements.